Core Viewpoint - The company is establishing a seed fund in collaboration with professional investment institutions to invest in strategic emerging industries, particularly in the biomedicine and high-end medical equipment sectors [1][2]. Group 1: Fund Establishment - The company, along with its designated subsidiaries, plans to sign a partnership agreement to establish the Shenzhen Yifeng Guangming Science City Seed Fund, with a maximum investment of 10 million RMB [1]. - The fund aims to support and develop strategic emerging industries and other key industries promoted by the Shenzhen government [1]. Group 2: Strategic Alignment - This investment aligns with the company's long-term development strategy and will leverage the resources and expertise of its partners to broaden investment channels [2]. - The collaboration is expected to provide momentum and assurance for the company's sustainable high-quality development [2]. Group 3: Risk Management - The company will benefit from the management experience and risk control systems of the fund managers, which will help mitigate investment risks and ensure project quality [2]. - The investment is not expected to have a significant adverse impact on the company's operations or performance, and it does not involve management changes or create competition [2].